Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Courtney

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Nature Communications|February 14, 2024
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancerChandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, et al.
Clinical Genitourinary Cancer|October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
Cancer Immunology Research|May 28, 2026
Targeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancerYaqing Zhang, Padma Kadiyala, Wei Yan, et al.
Cancer Discovery|March 20, 2021
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.
Cancer Letters|May 7, 2026
Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progressionChandra Sekhar Amara, Danthasinghe Waduge Badrajee Piyarathna, Abu Hena Mostafa Kamal, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Nature Communications|February 14, 2024
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancerChandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, et al.
Clinical Genitourinary Cancer|October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
Cancer Immunology Research|May 28, 2026
Targeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancerYaqing Zhang, Padma Kadiyala, Wei Yan, et al.
Cancer Discovery|March 20, 2021
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.
Cancer Letters|May 7, 2026
Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progressionChandra Sekhar Amara, Danthasinghe Waduge Badrajee Piyarathna, Abu Hena Mostafa Kamal, et al.
Pageof 14